Exhibit 99.1 303 International Circle P: 410.427.1700 Suite 200 F: 410.427.8800 Hunt Valley, MD 21030 PRESS RELEASE – FOR IMMEDIATE RELEASE OMEGA REPORTS FOURTH QUARTER AND FULL YEAR 2024 RESULTS Completed $340 Million in New Investments in Q4 2024 Issued $438M in Equity Providing 2025 Adjusted FFO Guidance Taylor Pickett, Omega's Chief Executive Officer, stated, "In the fourth quarter, we were again able to increase FAD per share sequentially, while continuing to de-lever the balance sheet. 2024 was a stro ...

Despite suffering setbacks during the Covid pandemic and operator health concerns, Omega Healthcare Investors, Inc. (NYSE: OHI ) has been able to defend its $0.67 per share per quarter dividend in the last couple of years.A financial researcher and avid investor with a keen eye for innovation and disruption, as well as growth buy-outs and value stocks. Keeping an eye on the pace of high tech and early growth companies, I write about current events and the biggest news surrounding the industry, and strive to ...

iREIT+HOYA Capital is the premier income-focused investing service on Seeking Alpha. Our focus is on income-producing asset classes that offer the opportunity for sustainable portfolio income , diversification , and inflation hedging . Get started with a Free Two-Week Trial and take a look at our top ideas across our exclusive income-focused portfolios.There’s something to be said about dividend stocks that keep pumping out cash dividends and shareholder returns while navigating through adversity. Examples ...

The benchmark S&P 500 index keeps reaching new highs, but not all of its components have participated in the rally. Royalty Pharma (RPRX 0.04%), W.P. Carey (WPC 0.56%), and Omega Healthcare Investors (OHI -0.13%) are three dividend payers with stock prices that have fallen recently.At their beaten-down prices, these stocks offer juicy dividend yields, and there's a good chance they can maintain or raise their payouts for at least a decade. Here's why adding these stocks to a diverse portfolio looks like a s ...

I am focused on growth and dividend income. My personal strategy revolves around setting myself up for an easy retirement by creating a portfolio which focuses on compounding dividend income and growth. Dividends are an intricate part of my strategy as I have structured my portfolio to have monthly dividend income which grows through dividend reinvestment and yearly increases. Feel free to reach out to me on Seeking AlphaAnalyst’s Disclosure: I/we have a beneficial long position in the shares of OHI either ...

The past couple of years have been terrific for stocks, with the benchmark S&P 500 index up a whopping 57.1% since the end of 2022. However, after the index's two-year bull run, it's getting harder to find quality dividend stocks that offer satisfying yields.The average stock in the S&P 500 index offers a yield of just 1.2%, but Pfizer (PFE 1.47%), W.P. Carey (WPC -0.78%), and Omega Healthcare Investors (OHI -0.15%) offer more than 6% at recent prices. These businesses support steadily rising dividend payou ...

For investors in the REIT sector over the past two years or so, it has not been easy seeing increased volatility due to uncertainty surrounding interest rates. With these remaining higher for longer, many have experienced lower growth as aContributing analyst to the iREIT+Hoya Capital investment group. The Dividend Collectuh is not a registered investment professional nor financial advisor and these articles should not be taken as financial advice. This is for educational purposes only and I encourage every ...

Omega Healthcare Investors, Inc. (NYSE:OHI) Q3 2024 Earnings Conference Call October 31, 2024 10:00 AM ET Company Participants Michele Reber - IR Taylor Pickett - CEO Dan Booth - COO Bob Stephenson - CFO Megan Krull - SVP, Operations Conference Call Participants Jonathan Hughes - Raymond James Michael Griffin - Citi John Kilichowski - Wells Fargo John Pawlowski - Green Street Nick Yulico - Scotia Bank Juan Sanabria - BMO Capital Markets Justin Haasbeek - RBC Capital Markets Alec Feygin - Baird Joe Dickstein ...

Financial Performance - The company reported a net income of $301.3 million for the nine months ended September 30, 2024, compared to $192.3 million for the same period in 2023, representing a 56.8% increase[224]. - The company reported a Nareit FFO of $538.3 million for the nine months ended September 30, 2024, compared to $462.3 million for the same period in 2023, reflecting a 16.4% increase[226]. - Rental income for the three months ended September 30, 2024, increased by $21.3 million to $231.5 million compared to $210.2 million in the same period of 2023[201]. - Interest income for the three months ended September 30, 2024, increased by $9.3 million to $39.9 million compared to $30.6 million in the same period of 2023[201]. - Rental income increased by $37.1 million due to facility acquisitions and lease extensions, while there was a net decrease of $23.3 million from cash basis operators[214]. - Interest income rose by $27.7 million due to new loans and additional fundings, with $212.8 million in new or existing real estate loans funded during the nine months ended September 30, 2024[215]. - The company reported net cash provided by operating activities of $520.5 million for the nine months ended September 30, 2024, an increase of $67.7 million compared to $452.8 million in 2023[248]. Acquisitions and Investments - The company acquired 66 facilities for an aggregate consideration of $445.7 million during the three months ended September 30, 2024[185]. - As of June 30, 2024, the company acquired the remaining 51% interest in the Cindat Joint Venture for a total consideration of $98.9 million in cash, a £188.6 million mortgage loan, and deferred contingent consideration valued at $2.0 million[192]. - The company invested $25.4 million in construction and capital improvement programs during the three months ended September 30, 2024[186]. - The company sold six facilities for $23.9 million in net cash proceeds, recognizing a net loss of $0.2 million during the three months ended September 30, 2024[187]. - The company experienced a $58.7 million decrease in gains on assets sold, with 15 facilities sold in 2024 compared to 37 in 2023[222]. Debt and Financing - The company financed $23.5 million of non-real estate loans originated during 2024 with a weighted average interest rate of 9.9%[191]. - The weighted average annual interest rate of the company's debt was 4.6% as of September 30, 2024, with 94.9% of the debt having fixed interest payments[232]. - The company has $478.5 million of interest rate swaps and £190.0 million of interest rate caps outstanding to hedge interest rate risks[255]. - The estimated fair value of total long-term fixed-rate borrowings was approximately $4.0 billion as of September 30, 2024[254]. - The company incurred interest expense of $8.6 million related to variable rate borrowings during the nine months ended September 30, 2024[253]. Regulatory and Operational Challenges - The company reported that certain operators have begun to recover from pandemic-driven challenges, but some remain impacted by labor shortages and occupancy declines[160]. - The healthcare industry is experiencing inflation-related cost increases, which may exacerbate labor shortages and increase labor costs for operators[162]. - A significant portion of operators' revenue is derived from government-funded reimbursement programs, primarily Medicare and Medicaid, which are subject to ongoing reform initiatives[167]. - The COVID-19 public health emergency allowed for temporary regulatory waivers and reimbursement rules, which have now expired, impacting operators' financial conditions[166]. - The ultimate scope and impact of recently issued federal minimum staffing rules for skilled nursing facilities remain uncertain and may affect operators' financial conditions[160]. - Operators have faced reimbursement delays due to a cybersecurity incident involving Change Healthcare, which may affect payment timing[163]. - The company anticipates that the operating results of certain operators may be materially and adversely affected if ongoing cost and occupancy impacts do not recover[161]. Shareholder Returns - The company declared a cash dividend of $0.67 per share on October 25, 2024, to be paid on November 15, 2024[200]. - Dividends paid to common stockholders for the nine months ended September 30, 2024, totaled $504.0 million, with a consistent dividend of $0.67 per share paid on three occasions[242]. - The company issued 11.6 million and 19.9 million shares under its ATM Programs, generating gross proceeds of $439.7 million and $703.9 million for the three and nine months ended September 30, 2024, respectively[238]. Assets and Equity - Total assets as of September 30, 2024, were $9.6 billion, with total equity of $4.4 billion and total debt of $4.9 billion, resulting in a debt-to-capitalization ratio of 52.6%[231]. - The company had $342.4 million in cash and cash equivalents as of September 30, 2024, with $1.2 billion of potential common share issuances remaining under the 2024 ATM Program[234]. - Cash, cash equivalents, and restricted cash totaled $360.3 million as of September 30, 2024, a decrease of $84.4 million from December 31, 2023[246]. - As of September 30, 2024, the company had 268.2 million shares of common stock outstanding, with a market value of $10.9 billion[238].

For the quarter ended September 2024, Omega Healthcare Investors (OHI) reported revenue of $276.03 million, up 14.1% over the same period last year. EPS came in at $0.74, compared to $0.37 in the year-ago quarter. The reported revenue compares to the Zacks Consensus Estimate of $261.64 million, representing a surprise of +5.50%. The company delivered an EPS surprise of +4.23%, with the consensus EPS estimate being $0.71. While investors closely watch year-over-year changes in headline numbers -- revenue and ...